Ross Summer
CEO, Jane & Leonard Korman Respiratory Institute · SIDNEY KIMMEL MEDICAL COLLEGE AT THOMAS JEFFERSON UNIVERSITY
Credentials: · · · · · · ·
History
PresentPulmonary Division · SIDNEY KIMMEL MEDICAL COLLEGE AT THOMAS JEFFERSON UNIVERSITY
- 1996–1999
Research
Adiponectin promotes macrophage polarization toward an anti-inflammatory phenotype
Journal of Biological Chemistry · 2010 · 553 citations
Bone marrow-derived cells as progenitors of lung alveolar epithelium
Development · 2001 · 421 citations
CD31- but Not CD31+ cardiac side population cells exhibit functional cardiomyogenic differentiation
Circulation Research · 2005 · 361 citations
17 papers
15 papers · 1 as a fellow
- JR
15 papers
- GL
9 papers
- CK
8 papers
7 papers
7 papers · 5 as a resident
6 papers · 5 as a fellow
Grants
- 2021–2026
Targeting Latexin Signaling for Endothelial Barrier Dysfunction in Inflammatory Lung Injury
National Heart, Lung, and Blood Institute · R01
PI · $2.8M · Thomas Jefferson University
- 2017–2021
Metabolic Control of DNA Repair in Pulmonary Fibrosis
National Heart, Lung, and Blood Institute · R01
Contact PI · $1.6M · Thomas Jefferson University
- 2020–2021
Soft LXR Agonists for Idiopathic Pulmonary Fibrosis
National Heart, Lung, and Blood Institute · R41
Contact PI · $306.5K · Fox Chase Chemical Diversity Center, Inc
- 2015–2018
Alcohol-Induced Lung Lipid Changes Contribute to Development of Acute Lung Injury
National Institute on Alcohol Abuse and Alcoholism · R21
Contact PI · $409.5K · Thomas Jefferson University
Clinical trials
- 2026–2031
Autoantibody Reduction Therapy for Progressive Idiopathic Pulmonary Fibrosis
Site PI · Not yet recruiting · Phase 2
University of Alabama at Birmingham
- 2026–2027
- 2025–2031
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
Site PI · Recruiting · Phase 2
Avalyn Pharma Inc.
- 2014–2031
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
Site PI · Recruiting
Duke University